172 related articles for article (PubMed ID: 2169575)
1. Distribution of somatostatin receptors in normal and tumor tissue.
Reubi JC; Kvols L; Krenning E; Lamberts SW
Metabolism; 1990 Sep; 39(9 Suppl 2):78-81. PubMed ID: 2169575
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo detection of somatostatin receptors in human malignant tissues.
Reubi JC; Kvols L; Krenning E; Lamberts SW
Acta Oncol; 1991; 30(4):463-8. PubMed ID: 1649613
[TBL] [Abstract][Full Text] [Related]
3. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptors in malignant tissues.
Reubi JC; Krenning E; Lamberts SW; Kvols L
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1073-7. PubMed ID: 1981010
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications.
Reubi JC; Laissue J; Krenning E; Lamberts SW
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):27-35. PubMed ID: 1356016
[TBL] [Abstract][Full Text] [Related]
6. The clinical use of somatostatin analogues in the treatment of cancer.
Lamberts SW; Krenning EP; Klijn JG; Reubi JC
Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):29-49. PubMed ID: 1975166
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EGF receptors.
Reubi JC; Waser B; Foekens JA; Klijn JG; Lamberts SW; Laissue J
Int J Cancer; 1990 Sep; 46(3):416-20. PubMed ID: 2168344
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor imaging with 123I-Tyr3-Octreotide.
Lamberts SW; Reubi JC; Bakker WH; Krenning EP
Z Gastroenterol; 1990 Sep; 28 Suppl 2():20-1. PubMed ID: 1980773
[TBL] [Abstract][Full Text] [Related]
9. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues.
Reubi JC; Laissue J; Waser B; Horisberger U; Schaer JC
Ann N Y Acad Sci; 1994 Sep; 733():122-37. PubMed ID: 7978860
[TBL] [Abstract][Full Text] [Related]
10. In vitro detection of somatostatin receptors in human tumors.
Reubi JC; Krenning E; Lamberts SW; Kvols L
Metabolism; 1992 Sep; 41(9 Suppl 2):104-10. PubMed ID: 1355582
[TBL] [Abstract][Full Text] [Related]
11. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors.
Reubi JC; Horisberger U; Lang W; Koper JW; Braakman R; Lamberts SW
Am J Pathol; 1989 Feb; 134(2):337-44. PubMed ID: 2537015
[TBL] [Abstract][Full Text] [Related]
12. The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer.
Reubi JC; Torhorst J
Cancer; 1989 Sep; 64(6):1254-60. PubMed ID: 2569925
[TBL] [Abstract][Full Text] [Related]
13. Photoaffinity labeling of the somatostatin receptor: identification of molecular subtypes.
Srikant CB; Murthy KK; Escher EE; Patel YC
Endocrinology; 1992 May; 130(5):2937-46. PubMed ID: 1349280
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptors in normal and tumoral tissue.
Reubi JC; Lamberts SW; Maurer R
Horm Res; 1988; 29(2-3):65-9. PubMed ID: 2900198
[TBL] [Abstract][Full Text] [Related]
15. In vitro detection of somatostatin receptors in human tumors.
Reubi JC; Krenning E; Lamberts SW; Kvols L
Digestion; 1993; 54 Suppl 1():76-83. PubMed ID: 8103015
[TBL] [Abstract][Full Text] [Related]
16. In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging.
Reubi JC
J Nucl Med; 1995 Oct; 36(10):1846-53. PubMed ID: 7562054
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptors in the gastrointestinal tract in health and disease.
Reubi JC
Yale J Biol Med; 1992; 65(5):493-503; discussion 531-6. PubMed ID: 1340064
[TBL] [Abstract][Full Text] [Related]
18. Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses.
Reubi JC; Heitz PU; Landolt AM
J Clin Endocrinol Metab; 1987 Jul; 65(1):65-73. PubMed ID: 3034958
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
[TBL] [Abstract][Full Text] [Related]
20. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.
Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW
Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
